StreetAlpha.app
Home › Stocks › BRVE

Braveheart Bio, Inc. (BRVE)

$20.39
▲ +5.81%
LAST CLOSE · NOV 20

Braveheart Bio, Inc. (BRVE) tracked by StreetAlpha. It last closed at $20.39 on Nov 20, up 5.81% on the day. The next earnings report for BRVE is expected around Tue, Feb 9, 2027, after the close. For the quarter ended Sep 2026, BRVE reported EPS of -$0.51. Over the last 12 months BRVE insiders bought $159.0M of stock on the open market and sold $0, according to SEC Form 4 filings.

AI Auto Pilots
Is BRVE in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold BRVE.
Next report
Feb 9
Estimated date · After the close
Reported EPS
-$0.51
Quarter ended Sep 2026
Year ago EPS
—
Same quarter last year
Revenue
—
Last reported quarter
Estimates and implied move
Consensus forecasts and the move options price in
How BRVE moved after its last 2 reports
Average move the session after a report ±4.1%
Nov 10, 2026After the close+6.5%
Sep 8, 2026After the close−1.7%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on BRVEStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on BRVE
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on BRVE

Technical Analysis

BRVE · as of the Nov 20 close · updated each morning
Falling

The stock sits between its 20 and 50 day averages. Momentum is improving (RSI 51). The nearest support is the 20 day average at $20.16, and the nearest resistance the swing high (Oct 12) at $20.78.

Short trendBearish
Long trendNot enough history
MomentumImproving
StretchNormal
VolatilityNormal, 8.1%/day
Key levels
$32.0052 week high+56.9%
$21.43Pivot R1+5.1%
$21.2350 day average+4.1%
$20.78Swing high (Oct 12)+1.9%
$20.39Last close
$20.1620 day average−1.1%
$20.12Pivot−1.3%
$19.09Pivot S1−6.4%
$18.00Swing low (Oct 16)−11.7%
$16.7052 week low−18.1%
Indicators
RSI (14)50.57Middle of its rangeNeutral
MACD-0.52Above its signal lineBullish
Stochastic52.4Middle of its rangeNeutral
ADX (14)20.3Weak trend
Williams %R-28.4Oversold below −80, overbought above −20Neutral
CCI (20)1.8Oversold below −100, overbought above 100Neutral
Rate of change+9.6%Change over 10 sessionsBullish
ATR (14)$1.66Typical daily range, 8.2% of price
MA 10Above
MA 20Above
MA 50Below
MA 100–
MA 200–
What happened before, for BRVE

What happened before

See how BRVE did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Whale Options Flow

90D
Whale options flow for BRVEHow many large options trades hit BRVE, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

BRVE Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲64 buying vs 0 selling
  • ▲Held by funds +81.5 pts
  • ●Funds holding +64
  • ▲Superinvestors: 2 added, 0 cut
  • ●Put/call not meaningful
Q3 2026This quarterLast quarterChange
Funds holding64––
In funds' top 105––
Held by funds81.5%––
New / increased64 / 0––
Reduced / sold out0 / 0––
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See BRVE institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

BRVE Insider Trading

All filings →
Insider trading · 12 months
Insiders are net buyers
Bought$159.0M10 buys · 10 insiders
Sold$00 sales · 0 insiders
Cluster buy: 10 insiders bought $159.0M between Aug 7 and Aug 7.
2026-08 bought $159.0MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Aug 7Orbimed Advisors LLCDirectorBuy1,940,000$18.00$34.9M
Aug 7Erez ChimovitsDirectorBuy1,940,000$18.00$34.9M
Aug 7AH Bio Fund IV, L.P.10% ownerBuy1,100,000$18.00$19.8M
Aug 7Forbion Growth Opportunities Fund III Cooperatief U.A.10% ownerBuy3,600,000$18.00$64.8M
Aug 7David Charles LubnerDirectorBuy55,555$18.00$1000K
Aug 7Travis MurdochCEO and PresidentBuy83,333$18.00$1.5M
Every insider buy and sale for BRVE over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See BRVE insider trades →

From SEC Form 4 filings by BRVE's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BRVE is in one of them and how their past BRVE trades turned out.

BRVE in the AI portfolios
Loading…

BRVE News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered BRVE in an article yet. Here's the latest on the wider market.

BRVE in the news